8th German Pharm-Tox Summit

P-glycoprotein inhibition by rifabutin distinguishes it from rifampicin and partly explains the unequal drug interaction risk

Drug transport/delivery and metabolism

Drug transport, metabolism and pharmacogenomics 

Oral presentation

Pharmacokinetics and PK/PD modelling	

Experimental characterization of human hepatic spheroids for enzyme induction studies in drug development

Disease models, drug development

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.  

Session 1

Poster

Stephanie Ruez

Further involvements